Loading organizations...
Loading organizations...
Developing small molecule therapeutics for Alzheimer's and cognitive declin
Cognition Therapeutics has raised $15.8M across 4 funding rounds.
Cognition Therapeutics has raised $15.8M in total across 4 funding rounds.
Cognition Therapeutics has raised $15.8M in total across 4 funding rounds.
Cognition Therapeutics's investors include Golden Seeds, ACE Fund, Ariel Southeast Angel Partners, Bios Memory SPV1, Cowtown Angels, Dolby Family Ventures, M5Invest Partners, Maine Angels, Ogden Cap, PLSG Accelerator Fund, Scale Investors, Tech Coast Angels.
Cognition Therapeutics has raised $15.8M across 4 funding rounds. Most recently, it raised $12.0M Series B in September 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 8, 2015 | $12.0M Series B | Golden Seeds | ACE Fund, Ariel Southeast Angel Partners, Bios Memory SPV1, Cowtown Angels, Dolby Family Ventures, M5Invest Partners, Maine Angels, Ogden Cap, PLSG Accelerator Fund, Scale Investors, Tech Coast Angels |
| Oct 11, 2013 | $140K Other Equity | Pittsburgh Life Sciences Greenhouse | |
| Jan 20, 2011 | $2.5M Series A | Nada Jain | Innovation Works, M5Invest Partners, Ogden Cap, Pittsburgh Life Sciences Greenhouse, Tech Coast Angels, Mark Breedlove, TMC Investment Company |
| Jul 17, 2009 | $1.2M Series A | Ogden Cap | Innovation Works, M5Invest Partners, Pittsburgh Life Sciences Greenhouse |